Literature DB >> 10925279

CD11c+ eosinophils in the murine thymus: developmental regulation and recruitment upon MHC class I-restricted thymocyte deletion.

M Throsby1, A Herbelin, J M Pléau, M Dardenne.   

Abstract

Eosinophils are bone marrow-derived cells released into the circulation during hypersensitivity reactions and parasitic infections. Under normal conditions most eosinophils are tissue bound, where their physiologic role is unclear. During in situ analysis of the thymic microenvironment for CD11c+ dendritic cell subpopulations (APC critical in the process of thymic negative selection) a discrete population of CD11b/CD11c double-positive cells concentrated in the cortico-medullary region of young mice was detected. Thymic CD11c+ cells were isolated, and the CD11b+ subpopulation (CD44high, class IIlow, CD11cint) was identified as mature eosinophils based on: scatter characteristics, major basic protein mRNA expression, and eosinophilic granules. They are hypodense, release high levels of superoxide anion, and express CD25, CD69, and mRNA for IL-4 and IL-13, but not GM-CSF or IL-5, suggesting a distinct state of activation. Thymic eosinophils are preferentially recruited during the neonatal period; absolute numbers increased 10-fold between 7-14 days to reach parity with dendritic cells before diminishing. In a model of acute negative selection, eosinophil numbers were increased 2-fold 6 h after cognate peptide injection into MHC class I-restricted female H-Y TCR transgenic mice. In both peptide-treated female and negatively selecting male H-Y TCR mice, clusters of apoptotic bodies were associated with eosinophils throughout the thymus. Our data demonstrate a temporal and spatial association between eosinophil recruitment and class I-restricted selection in the thymus, suggesting an immunomodulatory role for eosinophils under nonpathological conditions.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10925279     DOI: 10.4049/jimmunol.165.4.1965

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  40 in total

1.  Eosinophils in health and disease: the LIAR hypothesis.

Authors:  J J Lee; E A Jacobsen; M P McGarry; R P Schleimer; N A Lee
Journal:  Clin Exp Allergy       Date:  2010-04       Impact factor: 5.018

Review 2.  Eosinophils in innate immunity: an evolving story.

Authors:  Revital Shamri; Jason J Xenakis; Lisa A Spencer
Journal:  Cell Tissue Res       Date:  2010-11-03       Impact factor: 5.249

Review 3.  Eosinophils: important players in humoral immunity.

Authors:  C Berek
Journal:  Clin Exp Immunol       Date:  2015-09-28       Impact factor: 4.330

Review 4.  Origin, regulation and physiological function of intestinal oeosinophils.

Authors:  Patricia C Fulkerson; Marc E Rothenberg
Journal:  Best Pract Res Clin Gastroenterol       Date:  2008       Impact factor: 3.043

Review 5.  The Regulatory Function of Eosinophils.

Authors:  Ting Wen; Marc E Rothenberg
Journal:  Microbiol Spectr       Date:  2016-10

6.  Murine lung eosinophil activation and chemokine production in allergic airway inflammation.

Authors:  C Edward Rose; Joanne A Lannigan; Paul Kim; James J Lee; Shu Man Fu; Sun-sang J Sung
Journal:  Cell Mol Immunol       Date:  2010-07-12       Impact factor: 11.530

Review 7.  Biology of the eosinophil.

Authors:  Carine Blanchard; Marc E Rothenberg
Journal:  Adv Immunol       Date:  2009       Impact factor: 3.543

8.  Allergy, asthma, and inflammation: which inflammatory cell type is more important?

Authors:  Redwan Moqbel; Solomon O Odemuyiwa
Journal:  Allergy Asthma Clin Immunol       Date:  2008-12-15       Impact factor: 3.406

9.  Selective depletion of eosinophils or neutrophils in mice impacts the efficiency of apoptotic cell clearance in the thymus.

Authors:  Hye-Jung Kim; Eric S Alonzo; Guillaume Dorothee; Jeffrey W Pollard; Derek B Sant'Angelo
Journal:  PLoS One       Date:  2010-07-06       Impact factor: 3.240

Review 10.  Eosinophils: multifunctional and distinctive properties.

Authors:  Hirohito Kita
Journal:  Int Arch Allergy Immunol       Date:  2013-05-29       Impact factor: 2.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.